Oxytocin stimulates cell proliferation in vaginal cell line Vk2E6E7

Abstract

Objective

During and after menopause, the symptoms of vaginal atrophy cause great discomfort and necessitate effective treatment options. Currently, vaginally applied oxytocin is being investigated as a treatment for the symptoms of vaginal atrophy in postmenopausal women. To clarify the mechanisms behind oxytocins effects on vaginal atrophy, the present study investigated the effects of oxytocin on cell proliferation in the cells of the Vk2E6E7 line, a non-tumour vaginal cell line. The study also compared the effects of oxytocin with those of estradiol (E2).

Study design

The effects of both oxytocin and E2 on the proliferation of Vk2E6E7 cells were investigated using Cell Proliferation ELISA BrdU Colorimetric Assay. The expression of both oxytocin and oxytocin receptor was studied in Vk2E6E7 cells using quantitative real-time polymerase chain reaction and immunofluorescent staining.

Main outcome measures

Cell proliferation and gene expression.

Results

Oxytocin increased cell proliferation both time dependently and dose dependently. This differed from the effect pattern observed in cells treated with E2. In addition, in oxytocin-treated cells, the oxytocin receptor was found to be co-localized with caveolin-1, indicating pro-proliferative signalling within the cell.

Conclusions

Oxytocin stimulates cell proliferation and the co-localization of oxytocin receptor with caveolin-1 in oxytocin-treated cells, supporting the role of oxytocin signalling in cell proliferation. In addition, these findings suggest that increased cell proliferation is one mechanism by which local vaginal oxytocin treatment increases vaginal thickness and relieves vaginal symptoms in postmenopausal women with vaginal atrophy.

Keywords

Oxytocin vaginal cell proliferation vaginal atrophy Vk2E6E7 cells

Get full access to this article

View all access options for this article.

References

Nappi

Palacios

Panay

. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 2015; 19: 188–197.

Anderson

Marathe

Pudney

. The structure of the human vaginal stratum corneum and its role in immune defense. Am J Reprod Immunol 2014; 71: 618–623.

Buchanan

Kurita

Taylor

. Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification. Endocrinology 1998; 139: 4345–4352.

Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013; 20: 888–902; quiz 3–4.

Kallak

Baumgart

Goransson

. Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors. Menopause 2014; 21: 383–390.

Kallak

Baumgart

Nilsson

. Vaginal gene expression during treatment with aromatase inhibitors. Clin Breast Cancer 2015; 15: 527–535.

Al-Saqi

Jonasson

Naessen

. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women. Post Reprod Health 2016; 22: 25–33.

Al-Saqi

Uvnas-Moberg

Jonasson

. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy. Post Reprod Health 2015; 21: 88–97.

Jonasson

Edwall

Uvnas-Moberg

. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study. Menopause Int 2011; 17: 120–125.

10.

Imanieh

Bagheri

Alizadeh

. Oxytocin has therapeutic effects on cancer, a hypothesis. Eur J Pharmacol 2014; 741: 112–123.

11.

Veening

de Jong

Waldinger

. The role of oxytocin in male and female reproductive behavior. Eur J Pharmacol 2015; 753: 209–228.

12.

Gimpl

Fahrenholz

. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81: 629–683.

13.

Denda

Takei

Kumamoto

. Oxytocin is expressed in epidermal keratinocytes and released upon stimulation with adenosine 5′-[gamma-thio]triphosphate in vitro. Exp Dermatol 2012; 21: 535–537.

14.

Deing

Roggenkamp

Kuhnl

. Oxytocin modulates proliferation and stress responses of human skin cells: implications for atopic dermatitis. Exp Dermatol 2013; 22: 399–405.

15.

Petersson

Lundeberg

Sohlstrom

. Oxytocin increases the survival of musculocutaneous flaps. Naunyn Schmiedebergs Arch Pharmacol 1998; 357: 701–704.

16.

Guzzi

Zanchetta

Cassoni

. Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene 2002; 21: 1658–1667.

17.

Rimoldi

Reversi

Taverna

. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains. Oncogene 2003; 22: 6054–6060.

18.

Parton

del Pozo

. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 2013; 14: 98–112.

19.

Fridolfsson

Roth

Insel

. Regulation of intracellular signaling and function by caveolin. FASEB J 2014; 28: 3823–3831.

20.

Richard

Zingg

. The human oxytocin gene promoter is regulated by estrogens. J Biol Chem 1990; 265: 6098–6103.

21.

Uhlen

Oksvold

Fagerberg

. Towards a knowledge-based human protein atlas. Nat Biotechnol 2010; 28: 1248–1250.

22.

Fichorova

Rheinwald

Anderson

. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod 1997; 57: 847–855.

23.

Kinsey

Bussolati

Bosco

. Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med 2007; 11: 96–110.

24.

Cassoni

Marrocco

Bussolati

. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells. Mol Cancer Res 2006; 4: 351–359.

25.

Cassoni

Catalano

Sapino

. Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells. Int J Oncol 2002; 21: 375–378.

26.

Cassoni

Sapino

Munaron

. Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines. Endocrinology 2001; 142: 1130–1136.

27.

Nilsson

Risberg

Heimer

. The vaginal epithelium in the postmenopause–cytology, histology and pH as methods of assessment. Maturitas 1995; 21: 51–56.

28.

Ellmann

Sticht

Thiel

. Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell Mol Life Sci 2009; 66: 2405–2426.

29.

Lin

Huang

Hsu

. Oxytocin promotes long-term potentiation by enhancing epidermal growth factor receptor-mediated local translation of protein kinase Mzeta. J Neurosci 2012; 32: 15476–15488.